Page last updated: 2024-08-25

3-deazaneplanocin and Tongue Neoplasms

3-deazaneplanocin has been researched along with Tongue Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, J; Jiang, H; Li, Q; Li, Z; Qiu, J; Wang, D; Wang, Y; Yang, J; Ye, J; Yuan, C; Zhang, W	1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and Tongue Neoplasms

Article	Year
The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer. Oncotarget, 2013, Volume: 4, Issue:12 Topics: Adenosine; Animals; Apoptosis; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Polycomb Repressive Complex 2; Random Allocation; RNA, Small Interfering; Tongue Neoplasms; Transfection; Tumor Cells, Cultured	2013

Article

Year

The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer.

Oncotarget, 2013, Volume: 4, Issue:12

Topics: Adenosine; Animals; Apoptosis; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Polycomb Repressive Complex 2; Random Allocation; RNA, Small Interfering; Tongue Neoplasms; Transfection; Tumor Cells, Cultured

2013